Cargando…

Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation

BACKGROUND: Splenic switch-off (SSO) is a marker of adequate adenosine-induced vasodilatation on cardiac magnetic resonance perfusion imaging. We evaluate the feasibility of quantitative assessment of SSO in myocardial positron emission tomography (PET) perfusion imaging using [(15)O]H(2)O. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Inkinen, Satu Irene, Hippeläinen, Eero, Uusitalo, Valtteri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635971/
https://www.ncbi.nlm.nih.gov/pubmed/37943363
http://dx.doi.org/10.1186/s13550-023-01045-7
_version_ 1785133109615788032
author Inkinen, Satu Irene
Hippeläinen, Eero
Uusitalo, Valtteri
author_facet Inkinen, Satu Irene
Hippeläinen, Eero
Uusitalo, Valtteri
author_sort Inkinen, Satu Irene
collection PubMed
description BACKGROUND: Splenic switch-off (SSO) is a marker of adequate adenosine-induced vasodilatation on cardiac magnetic resonance perfusion imaging. We evaluate the feasibility of quantitative assessment of SSO in myocardial positron emission tomography (PET) perfusion imaging using [(15)O]H(2)O. METHODS: Thirty patients underwent [(15)O]H(2)O PET perfusion with adenosine stress. Time-activity curves, as averaged standardized uptake values (SUV(avg)), were extracted from dynamic PET for spleen and liver. Maximum SUV(avg), stress and rest spleen-to-liver ratio (SLR), and the splenic activity concentration ratio (SAR) were computed. Optimal cut-off values for SSO assessment were estimated from receiver operating characteristics (ROC) curve for maximum SUV(avg) and SLR. Also, differences between coronary artery disease, myocardial ischemia, beta-blockers, and diabetes were assessed. Data are presented as median [interquartile range]. RESULTS: In concordance with the SSO phenomenon, both the spleen maximum SUV(avg) and SLR were lower in adenosine stress when compared to rest perfusion (8.1 [6.5, 9.2] versus 16.4 [13.4, 19.0], p < 0.001) and (0.81 [0.63, 1.08] versus 1.86 [1.73, 2.06], p < 0.001), respectively. During adenosine stress, the SSO effect was most prominent 40–160 s after radiotracer injection. Cut-off values of 12.6 and 1.57 for maximum SUV(avg) and SLR, respectively, were found based on ROC analysis. No differences in SAR, SLR(Rest), or SLR(Stress) were observed in patients with coronary artery disease, myocardial ischemia, or diabetes. CONCLUSIONS: SSO can be quantified from [(15)O]H(2)O PET perfusion and used as a marker for adequate adenosine-induced vasodilatation response. In contrary to other PET perfusion tracers, adenosine-induced SSO is time dependent with [(15)O]H(2)O.
format Online
Article
Text
id pubmed-10635971
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-106359712023-11-11 Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation Inkinen, Satu Irene Hippeläinen, Eero Uusitalo, Valtteri EJNMMI Res Original Research BACKGROUND: Splenic switch-off (SSO) is a marker of adequate adenosine-induced vasodilatation on cardiac magnetic resonance perfusion imaging. We evaluate the feasibility of quantitative assessment of SSO in myocardial positron emission tomography (PET) perfusion imaging using [(15)O]H(2)O. METHODS: Thirty patients underwent [(15)O]H(2)O PET perfusion with adenosine stress. Time-activity curves, as averaged standardized uptake values (SUV(avg)), were extracted from dynamic PET for spleen and liver. Maximum SUV(avg), stress and rest spleen-to-liver ratio (SLR), and the splenic activity concentration ratio (SAR) were computed. Optimal cut-off values for SSO assessment were estimated from receiver operating characteristics (ROC) curve for maximum SUV(avg) and SLR. Also, differences between coronary artery disease, myocardial ischemia, beta-blockers, and diabetes were assessed. Data are presented as median [interquartile range]. RESULTS: In concordance with the SSO phenomenon, both the spleen maximum SUV(avg) and SLR were lower in adenosine stress when compared to rest perfusion (8.1 [6.5, 9.2] versus 16.4 [13.4, 19.0], p < 0.001) and (0.81 [0.63, 1.08] versus 1.86 [1.73, 2.06], p < 0.001), respectively. During adenosine stress, the SSO effect was most prominent 40–160 s after radiotracer injection. Cut-off values of 12.6 and 1.57 for maximum SUV(avg) and SLR, respectively, were found based on ROC analysis. No differences in SAR, SLR(Rest), or SLR(Stress) were observed in patients with coronary artery disease, myocardial ischemia, or diabetes. CONCLUSIONS: SSO can be quantified from [(15)O]H(2)O PET perfusion and used as a marker for adequate adenosine-induced vasodilatation response. In contrary to other PET perfusion tracers, adenosine-induced SSO is time dependent with [(15)O]H(2)O. Springer Berlin Heidelberg 2023-11-09 /pmc/articles/PMC10635971/ /pubmed/37943363 http://dx.doi.org/10.1186/s13550-023-01045-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Inkinen, Satu Irene
Hippeläinen, Eero
Uusitalo, Valtteri
Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation
title Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation
title_full Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation
title_fullStr Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation
title_full_unstemmed Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation
title_short Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation
title_sort adenosine-induced splenic switch-off on [(15)o]h(2)o pet perfusion for the assessment of vascular vasodilatation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635971/
https://www.ncbi.nlm.nih.gov/pubmed/37943363
http://dx.doi.org/10.1186/s13550-023-01045-7
work_keys_str_mv AT inkinensatuirene adenosineinducedsplenicswitchoffon15oh2opetperfusionfortheassessmentofvascularvasodilatation
AT hippelaineneero adenosineinducedsplenicswitchoffon15oh2opetperfusionfortheassessmentofvascularvasodilatation
AT uusitalovaltteri adenosineinducedsplenicswitchoffon15oh2opetperfusionfortheassessmentofvascularvasodilatation